Integrated with Versa HD linear accelerator, Elekta has introduced new intra-fraction imaging capabilities within its X-ray Volume Imaging (XVI) system. During treatment, XVI now provides the tools to monitor and manage internal motion, supporting the clinician's efforts to increase therapeutic doses delivered to the tumor while reducing healthy tissue exposure.

At RSNA 2013, Carestream’s new Vue PACS (picture archive and communication system) Reporting (shown as works-in-progress) is designed to enable insertion of key images and quantitative comparisons such as vessel analysis and measurements from modalities into radiology reports, which is designed to aid clinicians in treatment planning.

UltraSPECT announced that MaineHealth, a family of hospitals and medical centers throughout Maine, has selected the UltraSPECT Xpress.Cardiac and Xpress3.Cardiac solutions as part of the organization’s strategy for reducing nuclear medicine (NM) dose and complying with the American Society of Nuclear Cardiology (ASNC) final guidelines effective Jan. 1, 2014. Maine Medical Partners (MMP) – MaineHealth Cardiology in South Portland is one of ten facilities within MaineHealth that is installing the product, with others scheduled to continue roll out before the end of 2013.

In patients with atrial fibrillation, delayed enhancement magnetic resonance imaging (DE-MRI) performed before ablative treatment can stage the degree of damaged heart tissue (atrial fibrosis) and help predict whether treatment will be successful or not, according to results of Delayed Enhancement — MRI determinant of successful Catheter Ablation of Atrial Fibrillation (DECAAF) trial.